Pulmatrix, INC. (PULM) — 10-Q Filings

10-Q Filings (5)

• Pulmatrix Cash Halves Amid Merger Uncertainty, Revenue Dries Up — Oct 16, 2025 Risk: high
  Pulmatrix, Inc. (PULM) reported a significant decline in financial performance for the nine months ended September 30, 2025, with revenues dropping to $0 from $
• Pulmatrix Zero Revenue, Pivots to Oncology via Cullgen Merger — Aug 6, 2025 Risk: high
  Pulmatrix, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company's net loss for the thr
• Pulmatrix, Inc. Files Q3 2024 10-Q Report — Nov 8, 2024 Risk: medium
  Pulmatrix, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results for the third quarter and the first nine mon
• Pulmatrix, Inc. Files Q2 2024 10-Q Report — Aug 13, 2024 Risk: medium
  Pulmatrix, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business operations.
• Pulmatrix, Inc. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: low
  Pulmatrix, Inc. (PULM) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Pulmatrix, Inc. filed a 10-Q report for the period ending March 31, 2024. T

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX